Current location - Recipe Complete Network - Food recipes - US Food and Drug Administration approves COVID-19 plasma therapy. What are the disadvantages?
US Food and Drug Administration approves COVID-19 plasma therapy. What are the disadvantages?
At present, the US Food and Drug Administration has approved COVID-19's social therapy. According to their statements, whether known or potential, if this social therapy is used to treat patients, the advantages will always outweigh the disadvantages.

But the World Health Organization immediately issued a different voice. It is pointed out that social therapy may cause some side effects, which may lead to fever or chills in the cured person, even lead to lung injury, or lead to blood circulation overload, because there is no unified conclusion that plasma therapy is completely useful for all diseases, and there is no unified conclusion that the treatment effect of COVID-19-infected people.

However, since the US Food and Drug Administration has approved this treatment method, it proves that the plasma treatment method has achieved certain results in some clinical trials, and since the outbreak of coronary pneumonia, there have been some voices in the world that plasma treatment should be adopted. For example, India used this method to treat patients before and successfully rescued a critically ill patient. However, according to the World Health Organization, although rehabilitation plasma therapy has a history of more than 100 years, and it is indeed effective for some patients, it is not certain whether this therapy is really effective for COVID-19 because it deals with different kinds of infectious diseases and diseases.

At present, many clinical trial results for this treatment method have been published all over the world, but the experimental results are uneven and there is no unified conclusion, which proves that the quality is still at a low level. In other words, social therapy cannot guarantee that 100% is useful to patients, and even the guarantee rate is less than 50%. Therefore, social organizations only recommend plasma therapy as experimental therapy, and we can't continue to see the effect of clinical evaluation. If there are side effects in the future, who will be responsible for this?